Stockscreener 앱 받기
207.11
0.60%
-1.24
전일 마감가:
$208.35
열려 있는:
$207.075
하루 거래량:
1.57M
Relative Volume:
0.73
시가총액:
$59.01B
수익:
$21.84B
순이익/손실:
$1.68B
주가수익비율:
35.53
EPS:
5.8293
순현금흐름:
$2.67B
1주 성능:
+2.15%
1개월 성능:
+5.46%
6개월 성능:
+16.18%
1년 성능:
-12.35%
1일 변동 폭
$206.65
$209.12
1주일 범위
$198.44
$209.27
52주 변동 폭
$162.29
$251.99
벡톤 디킨슨 Stock (BDX) Company Profile
명칭
Becton Dickinson Co
전화
(201) 847-6800
주소
ONE BECTON DR, FRANKLIN LAKES
BDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
벡톤 디킨슨 Stock (BDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-25 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-05-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-07-11 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-06-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 재개 | Raymond James | Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 재개 | Goldman | Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-07 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-02-07 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-05-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 개시 | Deutsche Bank | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-06-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-04-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-19 | 재개 | BofA/Merrill | Buy |
| 2018-01-05 | 업그레이드 | Citigroup | Sell → Neutral |
| 2018-01-05 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2017-12-29 | 재확인 | Deutsche Bank | Buy |
모두보기
벡톤 디킨슨 주식(BDX)의 최신 뉴스
Becton Dickinson EVP Garrison sells $334,005 in BDX stock - Investing.com India
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
BD secures FDA 510(k) clearance for EnCor EnCompass system - Yahoo
Lobbying Update: $1,496,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed - Quiver Quantitative
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 - Benzinga
BD receives FDA clearance for new breast biopsy system By Investing.com - Investing.com India
BD Receives FDA 510(k) Clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System - Finviz
Manning & Napier Advisors LLC Sells 29,843 Shares of Becton, Dickinson and Company $BDX - MarketBeat
FDA clears new BD device aimed at improving breast biopsies for patients - Stock Titan
Becton, Dickinson and Company $BDX Shares Sold by Pacific Capital Partners Ltd - MarketBeat
BD Names Shawn Bevec as Senior Vice President of Investor Relations - Finviz
BD Names Shawn Bevec as Senior Vice President of Investor Relations – Company Announcement - Financial Times
Sumitomo Mitsui Trust Group Inc. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Is Becton Dickinson (BDX) Pricing Reflect Its Recent Multi‑Year Share Price Declines - Yahoo Finance UK
Assessing Becton Dickinson (BDX) Valuation After Recent Share Moves And Business Separation Plans - Yahoo Finance
BD Announces $110M Investment - citybiz
BD (BDX) Invests $110M to Enhance Syringe Production in Nebraska - GuruFocus
S Bank Fund Management Ltd Raises Holdings in Becton, Dickinson and Company $BDX - MarketBeat
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs - Finviz
Becton Dickinson’s Strategic Pivot Enters Critical Phase - AD HOC NEWS
Nebraska plant gets $110M boost to make syringes for new biologic drugs - Stock Titan
Sterilization Services MarketGlobal Forecast 2025-2032: Coverage of B. Braun, Becton Dickinson, Belimed, Cardinal Health, Ecolab, STERIS, and Sotera Health - Yahoo Finance UK
Hardman Johnston Global Advisors LLC Decreases Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Oregon Public Employees Retirement Fund Purchases 8,019 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Robeco Institutional Asset Management B.V. Cuts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Waters and Biosciences & Diagnostic Solutions unit to combine for $17.5B - MSN
Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price - 富途牛牛
HB Wealth Management LLC Grows Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Cerity Partners LLC - MarketBeat
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $210 - 富途牛牛
Is BD (BDX) Quietly Recasting Its Surgical Innovation Story With Expanded Phasix Mesh Use in Europe? - simplywall.st
Is Becton Dickinson and Company (BOX) stock a top hedge fund pickJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
What to Expect From Becton, Dickinson and Company's Next Quarterly Earnings Report - Barchart.com
SG Americas Securities LLC Acquires 76,233 Shares of Becton, Dickinson and Company $BDX - MarketBeat
KLP Kapitalforvaltning AS Sells 31,300 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Benjamin Edwards Inc. Increases Stake in Becton, Dickinson and Company $BDX - MarketBeat
Stifel raises Becton Dickinson stock price target to $215 from $210 - Investing.com Nigeria
Becton Dickinson (BDX): Stifel Raises Price Target to $215 | BDX Stock News - GuruFocus
Stifel raises Becton Dickinson stock price target to $215 from $210 By Investing.com - Investing.com South Africa
Stifel Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $215 - 富途牛牛
The Truth About Becton Dickinson and Co (BDX): Quiet Healthcare Giant, Loud Money Moves - AD HOC NEWS
Becton, Dickinson and Company (BDX) Announces Blackout Period fo - GuruFocus
Becton Dickinson announces temporary blackout period for 401(k) plan stock fund - Investing.com Nigeria
Becton Dickinson & CoOn Dec 30, Bd 401(K) Plan to Enter Blackout Period Due to Waters DealSEC Filing - TradingView — Track All Markets
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Mcdaniel Terry & Co. Sells 74,357 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Bought by D.A. Davidson & CO. - MarketBeat
RBC sees durable growth profile at Becton Dickinson (BDX), raises target - MSN
Becton Dickinson & Co. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
BDX: B of A Securities Raises Becton Dickinson's Price Target | - GuruFocus
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $207 - 富途牛牛
벡톤 디킨슨 (BDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.84%
3.30%
자본화:
|
볼륨(24시간):